Cullinan Therapeutics Inc (CGEM) Live Share Price, Invest From India

Cullinan Therapeutics Inc Stock Performance

as on March 28, 2026 at 6:59 am IST

Day's Low
Day's High
$12.79
Day's Price Range
$13.77
$12.85
0.47%
Downside
7.16%
Upside
52 Week's Low
52 Week's High
$5.68
52-Week Price Range
$16.74
$12.85
55.80%
Downside
30.27%
Upside

Cullinan Therapeutics Inc share price movements today

Previous Close: $13.67
Open: $13.57
Volume: 580.7K
Day's Low - High: $12.79 - $13.77
52 Week Low - High: $5.68 - $16.74

Cullinan Therapeutics Inc Historical Returns

1 Month Return: -17.1 %
3 Month Return: + 23.92 %
1 Year Return: + 60.22 %
3 Year Return: + 22.61 %
5 Year Return: -67.58 %

Cullinan Therapeutics Inc Stock Fundamentals & Key Indicators

Check Cullinan Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$827.4M

EPS (TTM)

-3.0961

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-241.3M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-44.02%

Cullinan Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cullinan Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Cullinan Therapeutics Inc	BUY	$827.4M	-67.58%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$43.5B	132.92%	140.84	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$115.2B	101.77%	29.58	32.94%
Beone Medicines Ltd	NA	$31.8B	NA	112.58	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$80.0B	54.69%	18.25	31.41%

Stock Returns calculator for Cullinan Therapeutics Inc Stock including INR - Dollar returns

The Cullinan Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Cullinan Therapeutics Inc investment value today

Current value as on today

₹1,70,733

Returns

₹70,733

(+70.73%)

Returns from Cullinan Therapeutics Inc Stock

₹60,224 (+60.22%)

Dollar Returns*

₹10,509 (+10.51%)

Analyst Recommendation on Cullinan Therapeutics Inc Stock

Based on 14 analysts

BUY

92.86%

Buy

7.14%

Hold

0.00%

Sell

Based on 14 analysts, 92.86% of analysts recommend a 'BUY' rating for Cullinan Therapeutics Inc. Average target price of $31.35

Cullinan Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Cullinan Therapeutics Inc.

What analysts predicted

59.01%UPSIDE

Target Price

$31.35

Current Price

$12.85

Analyzed by

14 Analysts

Target

$31.35

Cullinan Therapeutics Inc target price $31.35, a slight upside of 59.01% compared to current price of $12.85. According to 14 analysts rating.

Cullinan Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Cullinan Therapeutics Inc Stock has increased by 71% in the last 30 days, reflecting an upward trend in search activity.

Time period: February 26, 2026 to March 28, 2026

Change:71% versus previous 30 day period

Cullinan Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	-	0
Operating Income	-45	-45	-42	-50	-48	-55	-54	-75	-55	-55
EBITDA	-44	-45	-42	-49	-48	-54	-54	-75	-50	-60
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-39	-39	-37	-42	-40	-47	-48	-70	-50	-50
Income Tax Expense	-5	-14	0	-	-	0	-	-	-	-
Net Income	-39	-23	-37	-42	-40	-47	-48	-70	-50	-50
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Cullinan Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	18	18	-	-	-	-
Gross Profit	-	-	0	0	0	18	0	0	0	0
Operating Income	0	0	-14	-22	-60	-67	144	-191	-196	-241
EBITDA	-	-	-14	-22	-60	-67	-132	-190	-167	-241
Interest Expense	-	-	-	-	0	65	562	-	-	-
Depreciation	-	-	0	0	0	0	0	0	0	0
Income Before Tax	0	0	-14	-21	-59	-67	151	-169	-167	-219
Income Tax Expense	-	-	0	-1	-8	-2	42	-14	0	-
Net Income	0	0	-14	-20	-50	-65	111	-153	-167	-219
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-268.43%	-343.35%	0.00%	0.00%	0.00%	0.00%

Cullinan Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-23	-37	-42	-40	-47	-48	-70	-50	-50
Operating Cash Flow	-18	-38	-36	-34	-36	-43	-57	-36	-38
Investing Cash Flow	51	12	-185	19	15	36	53	67	22
Financing Cash Flow	0	1	262	1	1	-	0	-	0
Change in Cash	33	-24	40	-12	-19	-6	-3	30	-15

Cullinan Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	0	-14	-20	-51	-67	109	-153	-167	-219
Operating Cash Flow	0	-13	-20	-29	-43	-126	-134	-145	-175
Investing Cash Flow	-	0	-35	-5	-333	248	35	-136	179
Financing Cash Flow	0	0	85	140	268	-25	40	266	1
Change in Cash	0	-13	29	104	-108	96	-57	-15	5

Global Institutional Holdings in Cullinan Therapeutics Inc

Funds	Holdings
Patient Square Capital	1.47%
RTW INVESTMENTS, LLC	2.82%
Geode Capital Management, LLC	2.15%
Siren, L.L.C.	1.97%
Dimensional Fund Advisors, Inc.	1.4%

See all

Insights on Cullinan Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 6 months, CGEM stock has moved up by 115.6%
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, CGEM has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 68.3% return, outperforming this stock by 45.7%

About Cullinan Therapeutics Inc

cullinan oncology is focused on investing in and developing a highly diversified portfolio of oncology therapeutics with a unique, cost-efficient business model. sourced from the cullinan dry lab as well as external collaborators, cullinan’s assets are managed by a single, highly experienced team of oncology professionals and drug developers across a lean, capital efficient operating model.

Organisation	Cullinan Therapeutics Inc
Headquarters	One Main Street, Cambridge, MA, United States, 02142
Industry	Other Consumer Services
CEO	Mr. Nadim Ahmed
E-voting on shares	Click here to vote

Key Management of Cullinan Therapeutics Inc

Name	Title
Mr. Nadim Ahmed	President, CEO & Director
Dr. Patrick A. Baeuerle Ph.D.	Co-Founder, Chief Scientific Advisor & Chairman of Scientific Advisory Board
Nicholas Smith	Head of Investor Relations
Mr. Steve Andre	Chief Human Resources Officer
Ms. Rose Weldon	Senior Vice President of Corporate Affairs
Ms. Mary Kay Fenton CPA	Chief Financial Officer
Dr. Jeffrey Jones M.B.A., M.D., M.P.H.	Chief Medical Officer
Dr. Jennifer Michaelson Ph.D.	Chief Scientific Officer
Ms. Jacquelyn L. Sumer J.D.	Chief Legal Officer, Chief Compliance Officer & Corporate Secretary
Dr. Corinne Savill Ph.D.	Chief Business Officer

FAQs

What is Cullinan Therapeutics Inc share price today?

Cullinan Therapeutics Inc share price today is $12.85 as on March 28, 2026 at 1:29 am IST at the close of the market. Cullinan Therapeutics Inc share today touched a day high of $13.77 and a low of $12.79.

What is the 52 week high and 52 week low for Cullinan Therapeutics Inc share?

Cullinan Therapeutics Inc share touched a 52 week high of $16.74 on February 27, 2026 and a 52 week low of $5.68 on October 3, 2025. Cullinan Therapeutics Inc stock price today i.e. March 28, 2026 at 1:29 am IST is closed at $12.85,which is 23.24% down from its 52 week high and 126.23% up from its 52 week low.

What is Cullinan Therapeutics Inc's market capitalisation today?

Cullinan Therapeutics Inc market capitalisation is $0.00T as on March 28, 2026 at 1:29 am IST.

How to invest in Cullinan Therapeutics Inc Stock (CGEM) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cullinan Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cullinan Therapeutics Inc Shares that will get you 0.1167 shares as per Cullinan Therapeutics Inc share price of $12.85 per share as on March 28, 2026 at 1:29 am IST.

What is the minimum amount required to buy Cullinan Therapeutics Inc Stock (CGEM) from India?

Indian investors can start investing in Cullinan Therapeutics Inc (CGEM) shares with as little as ₹94.651 or $1 (as of March 28, 2026 at 3:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹946.51 in Cullinan Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on March 28, 2026 at 3:41 pm IST). Based on Cullinan Therapeutics Inc share’s latest price of $12.85 as on March 28, 2026 at 1:29 am IST, you will get 0.7782 shares of Cullinan Therapeutics Inc. Learn more about fractional shares .

What are the returns that Cullinan Therapeutics Inc has given to Indian investors in the last 5 years?

Cullinan Therapeutics Inc stock has given -67.58% share price returns and 29.26% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?